InvestorsHub Logo
Followers 9
Posts 402
Boards Moderated 0
Alias Born 04/22/2013

Re: gestalt2 post# 18012

Wednesday, 11/01/2017 8:19:58 PM

Wednesday, November 01, 2017 8:19:58 PM

Post# of 233221
Gestalt:

In my book any talk of an R/S is a moot point. If the forthcoming combo results are as we suspect coupled with what I believe will be amazing news regarding the first ten patients in the GVHD study - it's pretty much game over by end of first quarter.

When I listen to the excitement in Dr. Burger's voice when he speaks of the "stunning" results in the animal models and how PRO-140 COMPLETELY prevented any signs of GVHD in the mice when given a lethal dose of humanized bone marrow stem cells, how these animals were all healthy months later AND had developed new human immune systems - well that's just astonishing stuff.

And shareholders aren't the only parties taking notice. He further states during the Q & A portion of the conference that they're 'already in discussions with SEVERAL potential partners and submitted to them data from animal models - and that data has been perceived very well"-

If results break our way, probably bought by end of March--
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News